ABIOMED/ US0036541003 /
| 2022-12-21 10:00:00 PM | Chg. - | Volume | Bid1:50:32 AM | Ask1:50:32 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 381.0200USD | - | 20.61 mill. Turnover: 5.63 bill. |
381.3500Bid Size: - | 382.9700Ask Size: - | 17.18 bill.USD | - | 127.01 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.00 USD | -40.00% |
| EPS Diluted: | 2.98 USD | -39.68% |
| Revenues per Share: | 22.64 USD | 21.02% |
| Book Value per Share: | 32.99 USD | 12.39% |
| Cash Flow per Share: | 6.26 USD | 3.33% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 1,031.75 USD | 21.74% |
| Net Income: | 136.51 USD | -39.47% |
| Operating Cash Flow: | 285.39 USD | - |
| Cash and Cash Equivalents: | 132.82 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 127.01 | 110.41 |
| P/S Ratio: | 16.83 | 14.63 |
| P/BV ratio: | 11.55 | 10.04 |
| P/CF Ratio: | 60.83 | 52.88 |
| PEG: | -3.18 | -2.76 |
| Earnings Yield: | 0.79% | 0.91% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 17.18 bill. USD | 15.09 bill. USD |
| Free Float Market Cap.: | - USD | 11.11 bill. USD |
| Market Cap. / Employee: | 8.67 mill. USD | 7.53 mill. USD |
| Shares Outstanding: | 45.09 mill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | 13.64% |
| Net Profit Margin: | 13.23% |
| Return on Equity: | 9.08% |
| Return on Assets: | 8.16% |
Financial Strength
| Liquidity I / Cash Ratio: | 95.93% |
| Liquidity II / Quick Ratio: | 161.37% |
| Liquidity III / Current Ratio: | 705.25% |
| Debt / Equity Ratio: | 11.31% |
| Dynam. Debt / Equity Ratio: | 59.59% |
Efficiency
| Employees: | 2,003 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 515,103.84 USD |
| Net Income / Employee: | 68,150.27 USD |
| Total Assets / Employee: | 835,443.34 USD |
| * Fiscal Year End: | 2022-03-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
